Literature DB >> 15672437

Lymph node involvement in macroscopic medullary thyroid carcinoma.

P Tamagnini1, M Iacobone, F Sebag, M Marcy, C De Micco, J F Henry.   

Abstract

BACKGROUND: Medullary thyroid carcinoma (MTC) is a rare disease, with variable tendency to lymphatic spread. The aim of this retrospective study was to identify distinctive features of large MTC with and without nodal metastases.
METHODS: Between 1993 and 2003, 28 consecutive patients underwent total thyroidectomy and neck node dissection for sporadic MTC larger than 10 mm in diameter.
RESULTS: All tumours were confirmed to be malignant with a locally invasive pattern of growth. Lymph node metastases were present in 16 patients (N1) and absent in 12 (N0). There were no statistically significant differences between patients with N0 and N1 tumours concerning age (mean 52.1 versus 53.4 years), male:female ratio (0.7 versus 1.0), basal preoperative calcitonin concentration (mean 3238 versus 3076 pg/ml) and tumour size (23.3 versus 23.9 mm). There were differences in the incidence of tumour invasion (P < 0.001), vascular embolism (P = 0.011) and peritumoral thyroiditis (P = 0.039). Measurement of basal and stimulated calcitonin levels after surgery confirmed biochemical cure in all patients with N0 tumours and half of those with N1 disease (P = 0.006).
CONCLUSION: There were no preoperative factors that predicted node status for MTC larger than 1 cm in this series. Total thyroidectomy and nodal dissection remains the optimal treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15672437     DOI: 10.1002/bjs.4860

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.

Authors:  Christian Scheuba; Klaus Kaserer; Klaus Kaczirek; Reza Asari; Bruno Niederle
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.

Authors:  Francesca Torresan; Elisabetta Cavedon; Caterina Mian; Maurizio Iacobone
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?

Authors:  D Taïeb; S Giusiano; F Sebag; M Marcy; C de Micco; F F Palazzo; N J Dusetti; J L Iovanna; J F Henry; S Garcia; Colette Taranger-Charpin
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

4.  Is intraoperative calcitonin monitoring useful to modulate the extension of neck dissection in patients with medullary thyroid carcinoma?

Authors:  Carmela De Crea; Marco Raffaelli; Valentina Milano; Cinzia Carrozza; Cecilia Zuppi; Rocco Bellantone; Celestino P Lombardi
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

5.  Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

Authors:  Sébastien Aubert; Amandine Berdelou; Viviane Gnemmi; Hélène Behal; Robert Caiazzo; Michèle D'herbomez; Pascal Pigny; Jean Louis Wemeau; Bruno Carnaille; Florence Renaud; Brigitte Bouchindhomme; Emmanuelle Leteurtre; Michael Perrais; François Pattou; Christine Do Cao
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

Review 6.  Evidence-based approach to the management of sporadic medullary thyroid carcinoma.

Authors:  Jeffrey F Moley; Elizabeth A Fialkowski
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

7.  Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer.

Authors:  Andreas Machens; Steffen Hauptmann; Henning Dralle
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.